Acute toxicity, primary irritancy, and genetic toxicity studies with 3- (methylthio)propionaldehyde

Veterinary and Human Toxicology

Volumn 42, Issue 2, 2000, Pages 77-84

  Ballantyne, Bryan ^a   Myers, Roy C ^a  

^a UNION CARBIDE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (METHYLTHIO)PROPIONALDEHYDE; INDUSTRIAL CHEMICAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CHROMOSOME DAMAGE; CONJUNCTIVITIS; CORNEA INJURY; EDEMA; ERYTHEMA; EXPOSURE; EYE IRRITATION; FEMALE; GENETIC TOXICOLOGY; IRITIS; LD 50; MALE; MOUSE; MUTAGENICITY; NECROSIS; NONHUMAN; RAT; SKIN IRRITATION; TOXICOLOGY; VAPOR;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ALDEHYDES; ANIMALS; BONE MARROW; CORNEA; EYE INJURIES; FEMALE; IRRITANTS; LEUKEMIA L5178; MALE; MICE; MICRONUCLEUS TESTS; MUTAGENS; POINT MUTATION; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; SKIN; THYMIDINE KINASE;

ANIMALIA; ORYCTOLAGUS CUNICULUS; SALMONELLA TYPHIMURIUM; TYPHIMURIUM; ZEA MAYS;

EID: 0034021093     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Material Safety Data Sheet; Methylmercaptopropionaldehyde, Ref No B0360F. Union Carbide Corporation, Danbury, CT: March 30, 1999.
2. RTECS; Propionaldehyde, 3-(methylthio), Ref No UE2285000. Registry of the Toxic Effects of Chemical Substances, National Institute of Occupational Safety and Health, Cincinnati, OH. Distributed by Canadian Center for Occupational Health and Safety, CD Version, 99-3.
3. Carpenter CP, Kinkead ER, Geary DL Jr: Petroleum hydrocarbon toxicology studies. 1. Methodology. Toxicol Appl Pharm 32: 246-262, 1975.
4. Draize JH, Woodard G, Calvery HO: Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Expt Therap 82: 377-390, 1944.
5. Ames BH, McCann J, Yamaski E: Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mut Res 31: 47-364, 1975
6. Maron DN, Ames BH: Revised methods for the Salmonella mutagenicity test. Mutat Res 113: 173-215, 1983.
7. Mitchell AD, Myhr BC, Rudd CJ: Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Methods used and chemicals evaluated: Envir Molec Mutagen 12, Suppl 13: 1-18, 1988.
8. Ballantyne B, Cawley TJ, Blaszcak DL: Cutaneous toxicology of 3-(methylthio)propionaldehyde. J Toxicol Cutaneous Ocular Toxicol, in press.
9. Ballantyne B, Dodd DE, Pritts IM et al: Acute vapor inhalation toxicity of acrolein and its influence as a trace contaminant in 2-methoxy-3,4-dihydro-2H-pyran. Human Toxicol 8: 229-235, 1989.
10. Blazak WF, Stewart BE, Galperin I et al: Chromsome analysis of trifluorothymidine-resistant L5178Y mouse lymphoma cell colonies. Envir Mutag 8: 229-240, 1986.
11. Clive D, Batson AG, Turner NT: The ability of L5178Y/tk+/- mouse lymphoma cells to detect single gene and viable chromosome mutations. In Williams GM et al eds. The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation. Elsvier/North Holland Biomedical Press, New York: 103-123, 1980.
12. Hozier J, Sawyer J, Clive D et al: Cytogenetic distinction between the tk+ and tk- chromosomes in the L5178Y tk+/-cell line. Mut Res 105: 451-456, 1982.
13. Moore MM, Clive D, Howard BE: Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178/tk+/-mouse lymphoma cells. Mut Res 151: 141-159, 1985.
14. ATSDR. Toxicological Profile for Acrolein. Agency for Toxic Substances and Disease Registry, US Public Health Service, 1990.
15. Parent, RA, Caravello, HE, Harbell, JW: Gene mutation assay of acrolein in the CHO/HGPRT test system. J Appl Toxicol 11: 91-95, 1991.
16. Au W, Sokova OI, Kopnin B: Cytogenetic toxicity of cyclophosphamide and its metabolites in vitro. Cytogenet Cell Genet 26: 108-116, 1980.
17. Wilmer JM, Erexsun GL, Kligerman AD: Alteration of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites. Cancer Res 46: 203-210, 1986.
18. Crook TR, Souhami RL, Whyman GD: Glutothione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res 46: 503-5038, 1986.
19. Grafstrom RC, Dypbukt JM, Willey JC: Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res 48: 1717-1721, 1988.